Published in Neuroscience on January 01, 1990
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage (FITCH) | NCT04088630
Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia (2007) 5.67
A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A (1999) 3.96
Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A (1997) 3.59
Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol (2011) 3.20
Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med (2008) 3.08
Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun (2007) 3.07
The microglial sensome revealed by direct RNA sequencing. Nat Neurosci (2013) 2.73
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis (2009) 2.49
Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol (2007) 2.36
The role of microglia in amyloid clearance from the AD brain. J Neural Transm (Vienna) (2010) 2.21
Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci (2008) 2.20
Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A (2001) 1.95
Microglial activation and chronic neurodegeneration. Neurotherapeutics (2010) 1.87
Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A (2003) 1.87
Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol (2013) 1.82
Toll-like receptor 4 in CNS pathologies. J Neurochem (2010) 1.68
Axon initial segment-associated microglia. J Neurosci (2015) 1.67
Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun (2013) 1.66
Neutrophils express oncomodulin and promote optic nerve regeneration. J Neurosci (2013) 1.64
Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem (2006) 1.64
The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci (2009) 1.62
Origin and differentiation of microglia. Front Cell Neurosci (2013) 1.58
Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev (2014) 1.55
Olfaction in Parkinson's disease and related disorders. Neurobiol Dis (2011) 1.51
Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease. Clin Neurosci Res (2006) 1.50
Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One (2011) 1.49
Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response. J Neurosci (2008) 1.48
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect (2003) 1.47
The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun (2012) 1.42
Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets (2010) 1.37
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med (2004) 1.34
Rod microglia: elongation, alignment, and coupling to form trains across the somatosensory cortex after experimental diffuse brain injury. J Neuroinflammation (2012) 1.33
Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol (2013) 1.33
Microglia during development and aging. Pharmacol Ther (2013) 1.30
Do glial cells control pain? Neuron Glia Biol (2007) 1.30
Microglial activation - tuning and pruning adult neurogenesis. Front Pharmacol (2012) 1.29
A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J Neuroinflammation (2013) 1.29
Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci U S A (2004) 1.28
Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci (2014) 1.27
Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia (2012) 1.26
Factors regulating microglia activation. Front Cell Neurosci (2013) 1.26
Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci (2013) 1.26
Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol (2013) 1.24
Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol Ther (2009) 1.23
A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics (2007) 1.22
Inflammation and adaptive immunity in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.22
Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol (2012) 1.21
Innate and adaptive immunity for the pathobiology of Parkinson's disease. Antioxid Redox Signal (2009) 1.20
Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci (2016) 1.19
Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol (2010) 1.19
Microglia and spinal cord synaptic plasticity in persistent pain. Neural Plast (2013) 1.17
Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets (2011) 1.16
Functional diversity of microglia - how heterogeneous are they to begin with? Front Cell Neurosci (2013) 1.14
Microglial M1/M2 polarization and metabolic states. Br J Pharmacol (2015) 1.14
An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS One (2012) 1.14
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog Neurobiol (2011) 1.14
Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J Neuroinflammation (2013) 1.13
Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain (2010) 1.13
Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp Neurol (2010) 1.12
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflamm (2013) 1.12
Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp Neurol (2012) 1.10
Rod microglia: a morphological definition. PLoS One (2014) 1.10
Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. Pharmacol Ther (2011) 1.09
Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain Behav Immun (2011) 1.09
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J (2006) 1.09
Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J Neuroimmunol (2008) 1.09
Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br J Pharmacol (2006) 1.08
Oxidative stress and Parkinson's disease. Front Neuroanat (2015) 1.08
Immunity and inflammation in neurodegenerative diseases. Am J Neurodegener Dis (2013) 1.08
Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology (2012) 1.07
The changing phenotype of microglia from homeostasis to disease. Transl Neurodegener (2012) 1.06
Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci (2014) 1.06
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice. PLoS One (2013) 1.06
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol (2011) 1.06
Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist (2014) 1.05
Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link? Mol Neurobiol (2012) 1.04
Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med (1992) 1.04
Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase. Brain Res (2007) 1.04
Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc Natl Acad Sci U S A (1996) 1.03
A quantitative and morphometric study of the transformation of amoeboid microglia into ramified microglia in the developing corpus callosum in rats. J Anat (1992) 1.03
Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. J Neuroinflammation (2013) 1.03
Phosphoinositides regulate P2X4 ATP-gated channels through direct interactions. J Neurosci (2008) 1.03
The role of innate and adaptive immunity in Parkinson's disease. J Parkinsons Dis (2013) 1.03
Purinoceptors in microglia and neuropathic pain. Pflugers Arch (2006) 1.02
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci (2013) 1.00
TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD? Biochim Biophys Acta (2007) 1.00
IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS. PLoS One (2012) 1.00
Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J Neuroinflammation (2014) 0.99
Divergence between motoneurons: gene expression profiling provides a molecular characterization of functionally discrete somatic and autonomic motoneurons. Physiol Genomics (2005) 0.99
Osteopetrotic (op/op) mice have reduced microglia, no Abeta deposition, and no changes in dopaminergic neurons. J Neuroinflammation (2007) 0.99
Neurotransmitter signaling in the pathophysiology of microglia. Front Cell Neurosci (2013) 0.98
Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. Neurotoxicology (2009) 0.98
Microglia dynamics and function in the CNS. Curr Opin Neurobiol (2010) 0.97
Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function. Curr Drug Targets (2013) 0.97
Positron emission tomography imaging of neuroinflammation. J Child Neurol (2009) 0.97
Dual role of CD38 in microglial activation and activation-induced cell death. J Immunol (2008) 0.96
Imaging of microglia in patients with neurodegenerative disorders. Front Pharmacol (2012) 0.96
ATP receptors gate microglia signaling in neuropathic pain. Exp Neurol (2011) 0.96
Innate inflammation in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 0.96
F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol (1981) 12.96
Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA (2001) 10.63
Secretion of plasminogen activator by stimulated macrophages. J Exp Med (1974) 8.82
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet (2002) 8.70
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med (1992) 8.46
In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med (1974) 7.43
Immune recognition. A new receptor for beta-glucans. Nature (2001) 6.54
Macrophage receptors and immune recognition. Annu Rev Immunol (2005) 5.83
Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med (1975) 4.60
Secretion of a specific collagenase by stimulated macrophages. J Exp Med (1975) 4.56
Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process. J Exp Med (1974) 4.45
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Bipolar localization of the replication origin regions of chromosomes in vegetative and sporulating cells of B. subtilis. Cell (1997) 3.97
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Systemic inflammation and disease progression in Alzheimer disease. Neurology (2009) 3.79
Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med (1987) 3.74
Cellular and molecular mechanisms of action of bisphosphonates. Cancer (2000) 3.57
Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 3.44
Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med (1991) 3.30
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience (1985) 3.27
Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci (1989) 3.24
Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med (1985) 3.11
Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J Exp Med (1981) 2.89
Hippocampal specialization of food-storing birds. Proc Natl Acad Sci U S A (1989) 2.84
Turnover of resident microglia in the normal adult mouse brain. Neuroscience (1992) 2.73
Immunocytochemical characterization of the endocytic and phagolysosomal compartments in peritoneal macrophages. J Cell Biol (1992) 2.71
Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci U S A (1996) 2.69
Trypanosoma cruzi: modification of macrophage function during infection. J Exp Med (1977) 2.69
Macrophage-melanocyte heterokaryons. I. Preparation and properties. J Exp Med (1970) 2.65
Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med (1989) 2.63
Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med (1984) 2.53
The macrophage. Int Rev Cytol (1973) 2.52
Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J Biol Chem (1996) 2.44
Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J Clin Invest (2001) 2.41
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol (2008) 2.32
Macrophages and microglia in the nervous system. Trends Neurosci (1988) 2.32
Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey. Neuroscience (1984) 2.30
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med (1990) 2.29
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med (1981) 2.25
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J (1986) 2.21
Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids. J Cell Biol (1982) 2.16
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci (1993) 2.15
Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J Biol Chem (1993) 2.10
Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature (1990) 2.10
Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol (1989) 2.10
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07
Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med (2009) 2.06
CONGENITAL ECTROPION ASSOCIATED WITH BILATERAL PTOSIS-CASE REPORT. Br J Ophthalmol (1944) 2.06
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
Characterization of the human beta -glucan receptor and its alternatively spliced isoforms. J Biol Chem (2001) 2.03
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97
Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J Exp Med (1986) 1.96
Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics (1983) 1.96
Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience (1998) 1.94
Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol (2000) 1.94
Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol (1998) 1.92
The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. Anat Rec (1984) 1.91
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience (2002) 1.90
Efficacy of an internet-based behavioral weight loss program for overweight adolescent African-American girls. Eat Weight Disord (2005) 1.88
Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement. J Clin Invest (1985) 1.86
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.84
Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow. J Exp Med (1985) 1.83
Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol (1983) 1.80
Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature (1981) 1.80
Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J (1991) 1.79
Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun (2000) 1.77
Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol (2013) 1.77
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun (2009) 1.76
The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med (1987) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Trypanosoma cruzi: the immunological induction of macrophage plasminogen activator requires thymus-derived lymphocytes. J Exp Med (1977) 1.74
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science (1997) 1.70
Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J (1994) 1.70
Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood. J Exp Med (1986) 1.69
Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci (1999) 1.68
The ganglion cell and cone distributions in the monkey's retina: implications for central magnification factors. Vision Res (1985) 1.66
Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration (2002) 1.66
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol (1999) 1.65
Secretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor. J Exp Med (1979) 1.65
Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80. Development (1991) 1.65
The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun (2007) 1.65
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis (1999) 1.64
Macrophage activation selectively enhances expression of Fc receptors for IgG2a. J Exp Med (1983) 1.63